Leaflet DUSODRIL 100mg capsules


Indicated for: peripheral vascular disease; circulatory disorders

Substance: naftidrofuryl (vasodilator)

ATC: C04AX21 (Cardiovascular system | Peripheral vasodilators | Other peripheral vasodilators)

Naftidrofuryl is a vasodilator used for the treatment of peripheral vascular conditions such as peripheral arterial disease and Raynaud's syndrome. It works by improving blood flow and tissue oxygenation, reducing ischemic symptoms.

The medication is taken orally, usually two or three times daily, with the dose adjusted based on the severity of the condition. Common side effects include nausea, abdominal pain, diarrhea, and dizziness.

Naftidrofuryl is contraindicated in patients with hypersensitivity to the active substance or severe hepatic conditions. Its use also requires caution in patients at risk of kidney stones.

This medication is an effective option for managing peripheral vascular conditions, helping to alleviate symptoms and improve patients' quality of life.

General data about DUSODRIL 100mg

  • Substance: naftidrofuryl
  • Date of last drug list: 01-10-2015
  • Commercial code: W59244002
  • Concentration: 100mg
  • Pharmaceutical form: capsules
  • Quantity: 50
  • Product type: original
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: FAMAR L'AIGLE - FRANTA
  • Holder: MERCK SANTE S.A.S. - FRANTA
  • Number: 9999/2017/02
  • Shelf life: 3 years

Pharmaceutical forms available for naftidrofuryl

Concentrations available for naftidrofuryl

  • 100mg
  • 200mg